Altre lingue Alkem Laboratories Limited Bombay S.E.

Azioni

ALKEM

INE540L01014

Tempo differito Bombay S.E. Altri mercati azionari 10:26:03 11/07/2024			Variaz. 5gg	Var. 1 gen.
5.212 ^INR	-0,23%		+4,71%	+0,37%

09/07	Alkem Laboratories Limited annuncia un cambiamento nella dirigenza	CI
25/06	Alkem Laboratories ottiene la classificazione di 'Azione Volontaria Indicata' per lo stabilimento di Baddi, in India; le azioni salgono del 4%.	MT

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Alkem Laboratories Limited Announces Change in Management	09/07
Alkem Laboratories Gets 'Voluntary Action Indicated' for Baddi, India Facility; Shares Jump 4%	25/06
Alkem Laboratories Limited Announces Resignation of Dheeraj Sharma as an Independent Director	14/06
Alkem Laboratories Limited Receives an Order-In-Appeal Passed by Joint Commissioner (Appeals-II), Hyderabad Commissionerate, Telangana	10/06
Alkem Laboratories to Invest INR300 Million in HaystackAnalytics	07/06
Alkem Laboratories' Consolidated Profit Soars in Fiscal Q4; Shares Slump 6%	30/05
Alkem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	29/05
Alkem Laboratories Limited Recommends Final Dividend for Financial Year Ended March 31, 2024, Payable on and from 4 September, 2024	29/05
Alkem Laboratories Limited Receives an Order Passed by Additional Commissioner, Office of Additional Commissioner, Central GST SUB. - Commissionerate, Mohali: Chandigarh	15/05
Alkem Laboratories Limited Receives Order from Assistant Commissioner, GST & Central Excise, Cuttack-II Division, Cuttack and Superintendent, Central GST & Central Excise, Cuttack-II Division, Cuttack	07/05
Alkem Laboratories Limited Receives an Order from Assistant Commissioner, Ghatak 55, Range-14, Division 6, Gujarat	30/04
Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak	16/04
Alkem Laboratories Forms Subsidiary for Medical Devices Business	28/03
Alkem Laboratories Limited Announces Incorporation of Subsidiary Alkem Medtech Private Limited	28/03
Alkem Laboratories Gets 10 Observations from US FDA After Baddi, India Unit Inspection	28/03
Norway's Biosergen Secures Indian Regulatory Approval for Clinical Trial of Fungal Infections Therapy	12/02
Biosergen receives regulatory approval to test lead candidate BSG005 in patients with invasive fungal infection.	12/02
Alkem Laboratories Limited Approves Interim Dividend for Financial Year 2023-24 , Payable on 1 March, 2024	09/02
Alkem Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02
Research Update Biosergen: Licensing deal with Alkem and CTA submission	16/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Alkem Laboratories Limited Bombay S.E.

Azioni

ALKEM

INE540L01014

Altre lingue

Filtri